Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights

  Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO
  Highlights

Business Wire

NEW YORK -- May 15, 2013

Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference at 7 p.m.
EDT (6 p.m. CDT) on Sunday, June 2, 2013, to review data presented at the
Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Company executives will provide an overview of data presented at the meeting,
with a focus on the immuno-oncology portfolio, and address inquiries from
investors and analysts.

Investors and the general public are invited to listen to a live webcast of
the call at: http://investor.bms.com or by dialing 913-312-0641, confirmation
code: 3075561. Materials related to the call will be available at the same
website prior to the call. A replay of the call will be available beginning at
10 p.m. EDT on June 2 through 10 p.m. EDT on June 16. The replay can be
accessed at http://investor.bms.com or by dialing 402-280-9013, confirmation
code: 3075561.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to
discover, develop and deliver innovative medicines that help patients prevail
over serious diseases. For more information, please visit www.bms.com or
follow us on Twitter at http://twitter.com/bmsnews.

Contact:

Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com
or
Ranya Dajani, 609-252-5330
ranya.dajani@bms.com
or
Ryan Asay, 609-252-5020
ryan.asay@bms.com
 
Press spacebar to pause and continue. Press esc to stop.